JohnKingreyMD
Pulmonology • Oklahoma City, OKCritical Care Medicine, Interstitial Lung Diseases, Pleural Disease, Pulmonary Vascular Medicine
Director, Pulmonary Hypertension Center Oklahoma Heart Hospital
Dr. Kingrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3300 NW Expressway FL 4
Oklahoma City, OK 73112Phone+1 405-949-3349Fax+1 405-552-0450
Education & Training
Ohio State University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2014
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2007 - 2010
Saint Louis University School of MedicineClass of 2007
Certifications & Licensure
OK State Medical License 2014 - 2025
OH State Medical License 2007 - 2014- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
- Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH Start of enrollment: 2018 Jul 15
Publications & Presentations
PubMed
- 1 citationsParenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil.Chad E Miller, Veronica Franco, Jimmy S Smith, Vijay Balasubramanian, John Kingrey
Respiratory Medicine. 2023-11-01 - 3 citationsProvider recognition and response to echocardiographic findings indicating pulmonary hypertension in the Veterans affairs medical center population.John F. Kingrey, Ralph J. Panos, Jun Ying, Karthikeyan Meganathan, Robin Vandivier
Pulmonary Circulation. 2013-04-01 - 1 citationsExpert provider survey of longitudinal assessment in patients with pulmonary arterial hypertension.John F Kingrey, Christine Y Zhou, Bhavinkumar Dalal, Jean M Elwing
Heart & Lung. 2022-11-11
Press Mentions
I'm Aware That I'm Rare: The Phaware® PodcastNovember 5th, 2024- United Therapeutics Announces Top Line Data from the EXPEDITE Study of Remodulin Induction Prior to Orenitram TherapyOctober 31st, 2022
- United Therapeutics Highlights Poster Presentations from the Recent CHEST 2020 MeetingOctober 22nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
